🇺🇸 FDA
Pipeline program

PBCAR20A

PBCAR20A-01

Phase 2 gene_therapy completed

Quick answer

PBCAR20A for Non-Hodgkin's Lymphoma, Relapsed is a Phase 2 program (gene_therapy) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Non-Hodgkin's Lymphoma, Relapsed
Phase
Phase 2
Modality
gene_therapy
Status
completed

Clinical trials